(HealthDay)—Endovascular treatment (EVT) alone is neither superior nor noninferior to intravenous alteplase followed by EVT in a cohort of European patients with stroke, according to a study published in the Nov. 11 issue ...
Nov 22, 2021
0
3
(HealthDay)—For high-risk outpatients with COVID-19, fluvoxamine reduces the need for hospitalization, according to a study published online Oct. 27 in The Lancet Global Health.
Oct 29, 2021
0
3
(HealthDay)—Compared with placebo, neither aspirin nor apixaban reduces the rate of major adverse cardiovascular or pulmonary outcomes for clinically stable outpatients with symptomatic COVID-19, according to a study published ...
Oct 18, 2021
0
16
(HealthDay)—During the pandemic, cannabidiol (CBD) therapy reduced symptoms of burnout and emotional exhaustion among health care professionals working with COVID-19 patients, according to a study published online Aug. ...
Aug 13, 2021
0
5
(HealthDay)—Patients with chronic migraine (CM) and overlapping pain have worse pain-related physical function and psychosocial functioning than those with localized CM, according to a study recently published in Headache.
Aug 10, 2021
0
12
(HealthDay)—Cytisine treatment fails to demonstrate noninferiority to varenicline treatment for smoking cessation, according to a study published in the July 6 issue of the Journal of the American Medical Association.
Jul 8, 2021
0
1
(HealthDay)—Certain International Classification of Diseases (ICD), Tenth Revision (ICD-10) codes are recorded more frequently before the initial diagnosis in patients with multiple sclerosis (MS) compared with patients ...
Jun 25, 2021
0
3
(HealthDay)—For patients with early breast cancer, five years of zoledronate treatment after chemotherapy does not improve prognosis versus two years of treatment, according to a study published online June 24 in JAMA Oncology.
Jun 25, 2021
0
2
(HealthDay)—Electroacupuncture and auricular acupuncture are more effective than usual care at reducing chronic musculoskeletal pain in cancer survivors, according to a study published online March 18 in JAMA Oncology.
Apr 6, 2021
0
7
For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of the New England Journal of Medicine.
Apr 1, 2021
0
3
